In response to FDA safety review of mifepristone, 4 pro-choice states hit back
Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, attorneys general from four pro-choice states have fired back, filing a petition asking the U.S. regulator to lift restrictions on the treatment.
Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, attorneys general from four pro-choice states have fired back, filing a petition asking the U.S. regulator to lift restrictions on the treatment.
